Wojciech Barczak

14PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMolecular targetsCancer geneticsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 18, 2026
PRMT5-mediated intron retention triggers innate and adaptive immunity against cancer.

|Feb 25, 2023
Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response.

Wojciech Barczak, Simon M Carr, Geng Liu

|Feb 10, 2023
Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors.

Eunji Hong, Wojciech Barczak, Sujin Park

|Jan 26, 2023
The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity.

Geng Liu, Wojciech Barczak, Lian Ni Lee

|May 28, 2022
No Association between ABCB1 G2677T/A or C3435T Polymorphisms and Survival of Breast Cancer Patients-A 10-Year Follow-Up Study in the Polish Population.

Ewa Totoń, Barbara Jacczak, Wojciech Barczak

|Aug 27, 2021
miRNAs as Biomarkers for Diagnosing and Predicting Survival of Head and Neck Squamous Cell Carcinoma Patients.

Igor Piotrowski, Xiang Zhu, Tatiana Dandolini Saccon

Pageof 3

Frequent Collaborators

5 joint publications

Błażej Rubiś

5 joint publications

Nick B La Thangue

3 joint publications

Wiktoria Blaszczak

3 joint publications

Anastasia Samsonova